Preferred Label : Prostate Carcinoma;
NCIt synonyms : Cancer of Prostate; Cancer of the Prostate; Carcinoma of the Prostate; Carcinoma of Prostate;
NCIt related terms : Prostate Cancer; Prostate cancer, NOS; Other Prostate Carcinoma;
NCIt definition : One of the most common malignant tumors afflicting men. The majority of carcinomas
arise in the peripheral zone and a minority occur in the central or the transitional
zone of the prostate gland. Grossly, prostatic carcinomas appear as ill-defined yellow
areas of discoloration in the prostate gland lobes. Adenocarcinomas represent the
overwhelming majority of prostatic carcinomas. Prostatic-specific antigen (PSA) serum
test is widely used as a screening test for the early detection of prostatic carcinoma.
Treatment options include radical prostatectomy, radiation therapy, androgen ablation
and cryotherapy. Watchful waiting or surveillance alone is an option for older patients
with low-grade or low-stage disease.;
Alternative definition : NCI-GLOSS: Cancer that forms in tissues of the prostate (a gland in the male reproductive
system found below the bladder and in front of the rectum). Prostate cancer usually
occurs in older men.;
Neoplastic status : Malignant;
Codes from synonyms : 10036910; CDR0000445079;
Origin ID : C4863;
UMLS CUI : C0600139;
Automatic exact mappings (from CISMeF team)
Currated CISMeF NLP mapping
DO Cross reference
Disease excludes abnormal cell
Has associated anatomic sites
Semantic type(s)
UMLS correspondences (same concept)
Validated automatic mappings to NTBT
associated_with_malfunction_of_gene_product
concept_is_in_subset
disease_excludes_finding
disease_has_abnormal_cell
disease_has_accepted_treatment_with_regimen
disease_has_associated_gene
disease_has_finding
disease_has_normal_cell_origin
disease_has_normal_tissue_origin
disease_has_primary_anatomic_site
has_biomarker_gene
has_biomarker_gene_product
may_be_associated_disease_of_disease
neoplasm_has_special_category
https://www.has-sante.fr/jcms/p_3516751/fr/akeega-niraparib/acetate-d-abiraterone-cancer-de-la-prostate
2024
false
false
false
France
evaluation of the transparency committee
abiraterone
prostatism, nos
Prostate Carcinoma
prostatic neoplasms
Prostate Cancer pT2c TNM Finding v6 and v7
NCI CTEP SDC Prostate Cancer Sub-Category Terminology
Prostate Cancer Pathway
prostate cancer
neoplasm, malignant
prostate, nos
Abiraterone
abiraterone
malignant neoplasm prostate
---
https://www.has-sante.fr/jcms/p_3483677/fr/biopsies-ciblees-dans-le-diagnostic-du-cancer-de-la-prostate-rapport-d-evaluation
2023
France
health technology assessment
diagnosis
Prostate Cancer Pathway
Assay Target Antigen
Prostate Carcinoma
Biopsy of Prostate
prostatic neoplasms
malignant neoplasm prostate
prostate cancer
evaluation studies as topic
NCI CTEP SDC Prostate Cancer Sub-Category Terminology
prostate biopsy
biopsy
biopsy of prostate, nos
no diagnosis
Cancer Diagnosis
neoplasm, malignant
Prostate Cancer pT2c TNM Finding v6 and v7
---
https://pgtmsite.files.wordpress.com/2024/01/docetaxel_prostate_pgtm_20050407.pdf
2005
Canada
drug information
Docetaxel
prostatism, nos
Prostate Cancer Pathway
NCI CTEP SDC Prostate Cancer Sub-Category Terminology
Prostate Carcinoma
prostate cancer
docetaxel
docetaxel
neoplasm, malignant
Prostate Cancer pT2c TNM Finding v6 and v7
prostatic neoplasms
prostate, nos
Docetaxel
malignant neoplasm prostate
Refractory Carcinoma
---